A
Angela Largen
Publications - 3
Citations - 938
Angela Largen is an academic researcher. The author has contributed to research in topics: Epidemiology & Interquartile range. The author has an hindex of 2, co-authored 2 publications receiving 890 citations.
Papers
More filters
Journal ArticleDOI
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
William Sievert,Ibrahim Altraif,Homie Razavi,Ayman A. Abdo,Ezzat Ali Ahmed,Ahmed Alomair,Deepak Amarapurkar,Chien-Hung Chen,Xiaoguang Dou,Hisham El Khayat,Mohamed elShazly,Gamal Esmat,Richard Guan,Kwang Hyub Han,Kazuhiko Koike,Angela Largen,Geoff McCaughan,Sherif Mogawer,Ali Monis,Arif Nawaz,Teerha Piratvisuth,Faisal M. Sanai,Ala I. Sharara,Scott Sibbel,Ajit Sood,Dong Jin Suh,Carolyn Wallace,Kendra A. Young,Francesco Negro +28 more
TL;DR: The hepatitis C pandemic has been systematically studied and characterized in North America and Europe, but this important public health problem has not received equivalent attention in other regions.
Journal ArticleDOI
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Markus Cornberg,Homie Razavi,A. Alberti,Enos Bernasconi,Maria Buti,Curtis Cooper,Olav Dalgard,John F. Dillion,Robert Flisiak,Xavier Forns,Sona Frankova,Adrian Goldis,Ioannis Goulis,Waldemar Halota,Béla Hunyady,Martin Lagging,Angela Largen,Michael Makara,Spilios Manolakopoulos,Patrick Marcellin,Rui Tato Marinho,Stanislas Pol,Thierry Poynard,Massimo Puoti,Olga Sagalova,Scott Sibbel,Krzysztof Simon,Carolyn Wallace,Kendra A. Young,Cihan Yurdaydin,Eli Zuckerman,Francesco Negro,Stefan Zeuzem +32 more
TL;DR: A comprehensive review of the literature was used to gather country‐specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel.
Journal ArticleDOI
Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.
Samuel B. Holzman,Allison Perry,Paul Saleeb,Alexandra Pyan,C T Keh,Katya Salcedo,Masahiro Narita,Amina Ahmed,Thaddeus R. Miller,April C. Pettit,Renuka Khurana,Matthew Whipple,Dolly J. Katz,Angela Largen,Amy Krueger,Maunank Shah +15 more
TL;DR: Significant gaps were identified along the LTBI care cascade, with less than half of individuals diagnosed with LTBI initiating therapy, with further research needed to better characterize the factors impeding LTBI diagnosis, treatment initiation, and treatment completion.